A Controlled Trial of Erenumab for Episodic Migraine. [electronic resource]
Producer: 20171225Description: 2123-2132 p. digitalISSN:- 1533-4406
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Calcitonin Gene-Related Peptide Receptor Antagonists
- Chronic Disease
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Injections, Subcutaneous
- Least-Squares Analysis
- Male
- Middle Aged
- Migraine Disorders -- prevention & control
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.